Inactive Instrument

Other languages NVN Liquidation, Inc.

Equities

NVN Liquidation, Inc. Announces Board Resignations	05-01
Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc.	12-19
First Motion for Exclusivity Period Extension Approved For NVN Liquidation, Inc.	12-01
First Motion for Exclusivity Period Extension Filed by NVN Liquidation, Inc.	11-13
Novan, Inc. Announces the Resignation of John M. Gay as Secretary	27/09/23
Ligand Pharmaceuticals Incorporated completed the acquisition of Substantially All of the Assets of Novan, Inc. for $12.2 million.	26/09/23
Motion for Joint Administration Approved for Novan, Inc.	19/07/23
Sector Update: Health Care Stocks Slipping Late Monday	17/07/23
Top Midday Decliners	17/07/23
Sector Update: Healthcare Stocks Easing Monday Afternoon	17/07/23
Novan Files for Chapter 11 Bankruptcy Protection, to Sell Nearly All Assets to Ligand Pharmaceuticals	17/07/23
Motion for Joint Administration Filed by Novan, Inc.	17/07/23
Novan, Inc. Filed for Bankruptcy	17/07/23
Novan, Inc. Announces Board Changes	16/06/23
Novan to Cut Workforce by 50% Amid Restructuring	31/05/23
Novan, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Novan, Inc. Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement	27/04/23
Novan, Inc. Announces Principal Financial Officer Changes	07/04/23
Novan, Inc. Auditor Raises 'Going Concern' Doubt	29/03/23
Novan Says US FDA Accepted New Drug Application for Berdazimer Gel to Treat Molluscum Contagiosum	07/03/23

No results for this search